Communications biology · 2021
Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Palte Rachel L, Juan Veronica, Gomez-Llorente Yacob, Bailly Marc Andre, Chakravarthy Kalyan, Chen Xun, Cipriano Daniel, Fayad Ghassan N, Fayadat-Dilman Laurence, Gathiaka Symon, Greb Heiko, Hall Brian, Handa Mas, Hsieh Mark, Kofman Esther, Lin Heping, Miller J Richard, Nguyen Nhung, O'Neil Jennifer, Shaheen Hussam, Sterner Eric, Strickland Corey, Sun Angie, Taremi Shane, Scapin Giovanna
Аннотация
Human Arginase 1 (hArg1) is a metalloenzyme that catalyzes the hydrolysis of L-arginine to L-ornithine and urea, and modulates T-cell-mediated immune response. Arginase-targeted therapies have been pursued across several disease areas including immunology, oncology, nervous system dysfunction, and cardiovascular dysfunction and diseases. Currently, all published hArg1 inhibitors are small molecules usually less than 350 Da in size. Here we report the cryo-electron microscopy structures of potent and inhibitory anti-hArg antibodies bound to hArg1 which form distinct macromolecular complexes that are greater than 650 kDa. With local resolutions of 3.5 Å or better we unambiguously mapped epitopes and paratopes for all five antibodies and determined that the antibodies act through orthosteric and allosteric mechanisms. These hArg1:antibody complexes present an alternative mechanism to inhibit hArg1 activity and highlight the ability to utilize antibodies as probes in the discovery and development of peptide and small molecule inhibitors for enzymes in general.